Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine EdurantSelf-StudyKey Populations
Sign In or Register to get started
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 4 Overview
HIV in Older Adults - 0%Topic 1
BackgroundActivities - 0%Topic 2
Accelerated versus Accentuated AgingActivities - 0%Topic 3
Epidemiology of HIV in Older PersonsActivities - 0%Topic 4
Screening and Detection of HIV in Older AdultsActivities - 0%Topic 5
Antiretroviral Therapy in the Older Patient with HIVActivities - 0%Topic 6
Common Comorbid Conditions in Older Persons with HIVActivities - 0%Topic 7
Life Expectancy, Age of Death, and Advanced Care PlanningActivities - 0%Topic 8
Summary PointsActivities - HIV in Older Adults CE Quiz
HIV in Older Adults Overview
About this Lesson
Last Updated: February 3rd, 2025
CNE/CME Continuing Education
This lesson qualifies for:
View CE Notices
- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour and 1 CE contact hour (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: September 17th, 2018
CNE and CME Review: September 1st, 2023
CNE and CME Expiration: August 31st, 2026 (3rd Edition)
View CE Notices
Steps to Acquire CE for this Lesson:
1
Quiz
Score 80%+
2
Give Feedback
Complete survey
3
Print CE Certificate
Obtain proof of CE3rd Edition
This is a substantial revision of the original Lesson. The previous edition was titled HIV in Older Adults and available until September 1st, 2023.
Learning Objectives
- Recognize age-related and HIV-related changes to the immune systems of people 50 years of age and older
- Discuss the interplay of HIV and the aging process within the framework of accelerated and accentuated aging
- List recommendations for antiretroviral therapy management in persons 50 years of age and older.
- Explain expected virologic and immunologic responses to antiretroviral therapy in persons 50 years of age and older.
- Highlight comorbidities that more commonly occur in older adults with HIV
Lesson Contributors
Authors
Jehan Z. Budak, MD
Jehan Z. Budak, MD
Assistant Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Assistant Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures:
None
Reviewers
David H. Spach, MD
David H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures:
None
Lesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
Question Bank
Interactive board-review style questions about Epidemiology of HIV.
CNE/CME CME+MOC credits and CNE contact hours available.